Astaxanthin
astaxanthin
A red-algae carotenoid marketed as a super-antioxidant for skin, eyes and endurance.
TypeSupplement / dietary
The grade answers: What does the human evidence support for: Antioxidant, skin & eye support?
Grade
C
Limited
The grade rates evidence quality — it is not advice to take or buy.
- Class
- Carotenoid
- Primary use
- Antioxidant, skin & eye support
- Evidence strength
- low
- Last reviewed
- 2026-07-01
Bottom line
A potent antioxidant in the lab with small, promising human trials on skin and eye fatigue — but the 'super-antioxidant longevity' billing runs well ahead of the evidence.
What the evidence says
Astaxanthin is a carotenoid (giving salmon and shrimp their colour) that is a strong antioxidant in vitro and, unusually, distributes into skin and eye tissue. Small human trials suggest benefits for skin elasticity/hydration, eye fatigue, and possibly exercise-related oxidative markers. The studies are small, short and sometimes industry-linked, with no longevity outcomes. Grade C: a plausible cosmetic/ocular antioxidant with early human support, oversold as a systemic anti-aging agent.
Key studies
- [1]
- [2]
- [3]
Mechanism
A lipid-soluble antioxidant that quenches singlet oxygen and free radicals and spans cell membranes; may modulate inflammatory signalling.
Safety
Well tolerated; harmless colour changes are the main note. Generally regarded as safe at supplemental doses; long-term high-dose data are limited.
Dosage context
Trials commonly use ~4–12 mg/day. Natural (Haematococcus algae) sources are typically preferred over synthetic in the supplement market.
Examples of application
- Taken ~4–12 mg/day, usually a natural (algae) source, with food.
- Aimed at skin and eye support; evidence is small and early.
- A supporting antioxidant, oversold as a systemic anti-aging pill.
From the field
Astaxanthin has genuinely interesting tissue-distribution and some early skin/eye data — which the marketing inflates into a longevity super-pill. We grade it C and keep the cosmetic niche separate from the aging claim.